Press Releases

NEWARK, Calif., Feb. 6, 2020 /PRNewswire/ -- Intabio, a developer of instrumentation systems for biotherapeutic precision analysis and quality assessment throughout bioproduction, today announced a Series B investment of $18 million. The financing round was led by Northpond Ventures, with additional funds coming from Genoa Ventures and

WASHINGTON, Feb. 6, 2020 /PRNewswire/ -- The Get the Medications Right Institute (GTMRx) is issuing a call to action for health care stakeholders to optimize medication use as a way to save lives and save money when it convenes a stellar panel of health care policy leaders in Washington, D.C. at a

BLOOMFIELD, Conn., Feb. 6, 2020 /PRNewswire/ -- Total revenues were $153.6 billion. Adjusted revenues1 were $140.2 billion in 2019. Shareholders' net income for 2019 was $5.1 billion, or $13.44 per

STOCKHOLM, Feb. 6, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, 6th February 2020, the appointment of a leading oncology expert to its Scientific Advisory Board with the addition of Anne J. Ridley, PhD, Professor of Cell Biology and Head of School of Cellular and Molecular Medicine, University of

MINNEAPOLIS, Feb. 6, 2020 /PRNewswire/ -- Express Image Digital, the leader in digital wayfinding software that brings the power of improved customer experience with an integrated platform to help visitors navigate around campus, today announced its interactive Wayfinding Plus platform was selected by a large academic healthcare campus, with 4+ million square

BURNABY, BC, Feb. 6, 2020 /PRNewswire/ - Acuva Technologies Inc. ("Acuva" or "the Company") today announced the closing of a $5.4M growth financing with a syndicate of existing and new investors to deliver the Company's innovative drinking water purification systems to global consumers.

DALLAS, Feb. 6, 2020 /PRNewswire/ -- The American Heart Association, the world's leading nonprofit organization focused on heart and brain health for all, and its signature movement

SOUTH PLAINFIELD, N.J., Feb. 6, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that positive 1 year clinical data from Part 2 of the pivotal SUNFISH study evaluating risdiplam in people aged 2-25 years with nonambulatory type 2 and type 3 spinal muscular atrophy (SMA) were presented at the 2nd International SMA Europe Conference. T

BOULDER, Colo., Feb. 6, 2020 /PRNewswire/ -- Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced financial results for its fiscal 2020 third quarter that ended December 31, 2019.

PARIS, Feb. 6, 2020 /PRNewswire/ -- TargEDys® announces the successful completion of its 3 months, randomized, double blind, placebo-controlled, multicentric clinical study carried out on 229 subjects and evaluating the efficacy of Hafnia alvei HA4597™ in the weight loss by regulation of the appetite.